What proportion of lung cancer in never-smokers can be attributed to known risk factors
International Journal of Cancer,

Sisti J et al. – The results demonstrate the geographic variability of the epidemiology of lung cancer in never–smokers and highlight the need for further research in this area, particularly in Europe and North America.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Oncology Articles

1 Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial The Lancet, June 4, 2014    Evidence Based Medicine    Clinical Article

2 Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium International Journal of Cancer, June 23, 2014    Clinical Article

3 Timing of metabolic response monitoring during erlotinib treatment in non-small cell lung cancer The Journal of Nuclear Medicine, July 11, 2014    Clinical Article

4 Reduced risk of lung cancer with metformin therapy in diabetic patients: A systematic review and meta-analysis American Journal of Epidemiology, June 17, 2014    Evidence Based Medicine    Review Article
Exclusive Author Commentary

5 Identification of subsets of patients with favorable prognosis after recurrence in completely resected non-small cell lung cancer Annals of Surgical Oncology, July 17, 2014    Clinical Article

6 Ceritinib: First global approval Drugs, July 2, 2014    Review Article

7 Interferon alpha plus 13-cis-retinoic acid modulation of BCL-2 plus paclitaxel for recurrent small-cell lung cancer (SCLC): an Eastern Cooperative Oncology Group study (E6501) Cancer Chemotherapy and Pharmacology, July 7, 2014    Clinical Article

8 Increase in the use of lung stereotactic body radiotherapy without a preceding biopsy in the United States Lung Cancer, July 1, 2014    Clinical Article

9 EGFR expression and survival in patients given cetuximab and chemoradiation for stage III non-small cell lung cancer: A secondary analysis of RTOG 0324 Radiotherapy & Oncology, July 24, 2014    Clinical Article

10 Nimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small-cell lung cancer: a multicenter, randomized, open-label Phase II study Full Text OncoTargets and Therapy, July 8, 2014    Free full text    Clinical Article

11 A panel of protein markers for the early detection of lung cancer with bronchial brushing specimens Cancer Cytopathology, July 21, 2014    Clinical Article

12 Pulmonary function after lobectomy versus segmentectomy in patients with stage I non-small cell lung cancer World Journal of Surgery, July 15, 2014    Clinical Article

13 Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad Endocrine-Related Cancer, July 18, 2014    Clinical Article

14 Association of PD-L1 overexpression with activating EGFR mutations in surgically resected non–small cell lung cancer Annals of Oncology, July 11, 2014    Clinical Article

15 Afatinib combined with cetuximab for lung adenocarcinoma with leptomeningeal carcinomatosis Lung Cancer, July 1, 2014

16 Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors Cancer Treatment Reviews, June 23, 2014    Review Article

17 Efficacy and safety of maintenance pemetrexed in patients with advanced nonsquamous non-small cell lung cancer following pemetrexed plus cisplatin induction treatment: a cross-trial comparison of two phase III trials Lung Cancer, July 22, 2014    Clinical Article

18 Hepatitis B virus reactivation in hepatitis B surface antigen seropositive patients with metastatic non-small cell lung cancer receiving cytotoxic chemotherapy: the efficacy of preemptive lamivudine and identification of risk factors Medical Oncology, July 18, 2014

19 Prognostic and predictive role of ERCC1 protein expression in locally advanced stage III non-small cell lung cancer Medical Oncology, June 19, 2014    Clinical Article

20 A randomized, phase 2 trial of docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic non–small-cell lung cancer Journal of Thoracic Oncology, July 10, 2014    Clinical Article

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncologymore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close